These studies will provide valuable insights into the long-term efficacy, safety, and tolerability of this triple-hormone receptor agonist, as well as its potential impact on cardiovascular outcomes
Bear in mind: TRIUMPH-4 enrolled obesity plus knee OA, so the population is not identical to the general obesity cohort
Because GLP-1 levels normalize, dopamine pathways rebound, microbiome damage persists, and SCFA-based satiety signals remain impaired
While dosage calculators provide helpful guidance, you should always consult a healthcare professional before making any changes to your medication regimen
Cardiovascular outcomes trials for weight loss interventions: another tool for cardiovascular prevention
Retatrutide has a six-day half-life, which means partial therapeutic levels persist even when a dose is missed, but consistency is important for steady adaptation during the starting period